drugset / Trial / NCT01052610

Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

NCT01052610 ↗

Phase 4 Unknown 100 enrolled Medical University of Lodz
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the trial is to asses the efficacy and safety of sublingual annual immunotherapy in children with bronchial asthma and/or allergic rhinitis allergic to house dust mites.

Timeline

Start
2010-06
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator house dust mites allergen extract Other / unclassified — Other